| Outcomes
The main outcome of this study was the choice of therapeutic strategy:
Surgical versus non-surgical treatment (RT and/or CRT). The surgical subgroup included patients undergoing surgical resection alone as well as those who may have received RT and/or CT in addition to surgery.
Local tumor excision, such as polypectomy, was not considered sufficient to categorize the treatment strategy as surgical. A secondary outcome for this study was the identification of patient, tumor, treatment, and institution-related factors associated with improved OS for patients treated with primary surgery.
| Covariates
Overall T (pathologic or clinical) stages were used in this study to investigate a potential association between disease stage and choice of therapeutic strategy. The patient sociodemographic factors analyzed in this study included: Sex age, race, insurance status (private, government, and uninsured), and Charlson-Deyo comorbidity score.
Treatment facility type was defined as either academic, which included all academic programs as well as National Cancer Institute Comprehensive Cancer Centers (NCI CCC), or as community, which included community cancer programs and comprehensive community cancer programs. Hospital volume was defined as the total number of new SNSCC cases treated overall from 2003 to 2012, with all hospitals divided into fewer than and more than 50 cases for statistical analysis.
OS was defined as the number of months between the date of diagnosis and the date on which the patient was last contacted or died.
| Statistical analysis
All analyses were conducted using Stata statistical software (release 12.1; StatCorp LP, College Station, TX). This study utilized multivariable logistic regression compare patient, tumor, and treatment centerspecific factors that contributed to selecting surgery as the primary treatment modality for SNSCC. A secondary analysis of factors that contributed to improve OS was performed utilizing multivariable Cox proportional hazard regression and Kaplan-Meier statistics. P values <0.05 were considered statistically significant. Table 1 . Three-thousand and fifty-two (64%) patients were male and 4102 (86%) patients were white. Forty-seven percent of patients (2241) were under the age of 65, and 3816 (80%) patients had a Charlson-Deyo score of 0. Two-thousand six-hundred and eighty-two patients (60%) were covered by government insurance. Two-thousand four-hundred and thirty-two patients (51%) were treated at academic or NCI CCC facilities. Low-volume hospitals that saw ≤50 patients with SNSCC in total from 2003 to 2012 treated 3577 (75%) of patients. The most common tumor site was the nasal cavity for 2528 patients (53%), followed by the maxillary sinus for 1955 patients (41%). Regarding the staging of SNSCC cases, the largest
proportion of patients had tumors with an overall T stage of T1 (1478 or 31%) while 763 (16%), 763 (16%), 1192 (25%), and 572 (12%) of patients had T2, T3, T4a and T4b tumors, respectively. Lymph node metastases were reported in 334 patients (7%) and distant metastases were reported in 131 patients (3%). In cases with negative margin resection, patients were more likely to have surgery alone (no adjuvant treatment 993 patients or 82.0%), while when macroscopic and microscopic positive margins were present patients were more likely to have adjuvant therapy (no adjuvant treatment 758 patients or 62.6%) (P < 0.001). Figure 1A .
Patients with negative margin resection had improved survival when compared to either a microscopic or macroscopic positive margin resection (P < 0.001). Patients with microscopic versus macroscopic positive margin were not significantly different in Figure 1B .
On multivariate analysis, patient, tumor, and treatment factors affected survival in Table 2 . Poorer survival was associated with patient factors including increased age (>80 years old vs < less than 50:
Hazard ratio (HR) 2.71, CI 1.89-3.89, P < 0.001) and increased Table 4 . Additionally, a number of SNSCC cases were potentially excluded due to exclusion of overlapping lesions in the nasopharynx or of the accessory sinuses. Third, although we did not consider "local tumor excision" or "polypectomy" to be surgical treatment approaches, it is possible that such patients did in fact undergo surgery for oncologic therapy or those others that were included in the surgical subgroup, did not in fact undergo primary surgical resection. In addition, we removed patients without complete data sets, which could potentially bias results.
| CONCLUSIONS
Primary surgical resection is utilized in the minority of patients with SNSCC and its utilization in this patient population has remained 
